Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Urakami

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Acta Neurologica Scandinavica|March 1, 1995
Cu, Zn superoxide dismutase in patients with dementia of the Alzheimer typeK Urakami, K Sato, A Okada, et al.
Biochemical and Biophysical Research Communications|February 15, 1989
In vitro and in vivo antagonists against parathyroid hormone-related proteinK Nagasaki, K Yamaguchi, Y Miyake, et al.
Nucleic Acids Symposium Series|January 1, 1983
Oligoribonucleotide synthesis by use of nucleotide units masked with new protecting groups on the base residues of guanosine and uridineT Kamimura, T Masegi, K Urakami, et al.
Dementia and Geriatric Cognitive Disorders|April 15, 2000
Lipoprotein(a) phenotypes in patients with vascular dementiaK Urakami, K Wada-Isoe, Y Wakutani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's diseaseY Wakutani, K Watanabe, Y Adachi, et al.
Neuroepidemiology|January 1, 1996
Prevalence of neurological disorders in a Japanese townK Nakashima, Y Yokoyama, R Shimoyama, et al.
Neuroscience Letters|February 20, 1999
A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsyK Urakami, M Mori, K Wada, et al.
Dementia and Geriatric Cognitive Disorders|August 15, 2000
The expression of presenilin 1 mRNA in skin fibroblasts and brains from sporadic Alzheimer's diseaseK Ikeda, K Urakami, H Arai, et al.
Annals of Neurology|August 17, 2001
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's diseaseN Itoh, H Arai, K Urakami, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 1998
Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in JapanT Nishimura, M Takeda, Y Nakamura, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Acta Neurologica Scandinavica|March 1, 1995
Cu, Zn superoxide dismutase in patients with dementia of the Alzheimer typeK Urakami, K Sato, A Okada, et al.
Biochemical and Biophysical Research Communications|February 15, 1989
In vitro and in vivo antagonists against parathyroid hormone-related proteinK Nagasaki, K Yamaguchi, Y Miyake, et al.
Nucleic Acids Symposium Series|January 1, 1983
Oligoribonucleotide synthesis by use of nucleotide units masked with new protecting groups on the base residues of guanosine and uridineT Kamimura, T Masegi, K Urakami, et al.
Dementia and Geriatric Cognitive Disorders|April 15, 2000
Lipoprotein(a) phenotypes in patients with vascular dementiaK Urakami, K Wada-Isoe, Y Wakutani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's diseaseY Wakutani, K Watanabe, Y Adachi, et al.
Neuroepidemiology|January 1, 1996
Prevalence of neurological disorders in a Japanese townK Nakashima, Y Yokoyama, R Shimoyama, et al.
Neuroscience Letters|February 20, 1999
A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsyK Urakami, M Mori, K Wada, et al.
Dementia and Geriatric Cognitive Disorders|August 15, 2000
The expression of presenilin 1 mRNA in skin fibroblasts and brains from sporadic Alzheimer's diseaseK Ikeda, K Urakami, H Arai, et al.
Annals of Neurology|August 17, 2001
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's diseaseN Itoh, H Arai, K Urakami, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 1998
Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in JapanT Nishimura, M Takeda, Y Nakamura, et al.
Pageof 8